Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025)

BioNexus Gene Lab's Work In Process history spans 2 years, with the latest figure at $190588.0 for Q3 2025.

  • For Q3 2025, Work In Process changed N/A year-over-year to $190588.0; the TTM value through Sep 2025 reached $190588.0, changed N/A, while the annual FY2024 figure was $188797.0, N/A changed from the prior year.
  • Work In Process for Q3 2025 was $190588.0 at BioNexus Gene Lab, up from $188797.0 in the prior quarter.
  • Across five years, Work In Process topped out at $190588.0 in Q3 2025 and bottomed at $188797.0 in Q4 2024.